Thyroid hormone autoantibodies (THAA) in two cases of Graves' disease: effects of antithyroid drugs, prednisolone, and subtotal thyroidectomy.
Changes in titers of serum thyroid hormone autoantibodies (THAA) and anti-thyroglobulin (Tg) antibodies during treatment with antithyroid drugs (methimazole and propylthiouracil) were examined in two cases of Graves' disease. Effects of prednisolone and subtotal thyroidectomy were also investigated in one case (case 1). Initially both cases had only anti-T4 autoantibodies in their serum. During methimazole therapy, the titer of anti-T4 autoantibodies increased in both cases, and anti-T3 autoantibodies became detectable and their titer increased in case 2. The influence of propylthiouracil on the titer of THAA was not clear. Both prednisolone plus methimazole therapy and subtotal thyroidectomy decreased the level of anti-T4 autoantibodies in case 1. There was a significant correlation between titers of THAA and anti-Tg antibodies in both cases, although titers of anti-Tg antibodies in case 1 stayed within the normal range throughout the investigation period. These results indicate that methimazole treatment could induce and/or enhance the production of THAA and THAA are antibodies against thyroid hormone-containing Tg molecule.
D001323:Autoantibodies / Q000032:analysis*; D002648:Child; D005260:Female; D006111:Graves Disease / Q000276:immunology* / Q000628:therapy; D006801:Humans; D008713:Methimazole / Q000627:therapeutic use; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011441:Propylthiouracil / Q000627:therapeutic use; D013954:Thyroglobulin / Q000276:immunology; D013963:Thyroid Hormones / Q000276:immunology*; D013965:Thyroidectomy; D013974:Thyroxine / Q000276:immunology; D014284:Triiodothyronine / Q000276:immunology
D001323:Autoantibodies; D013963:Thyroid Hormones; D014284:Triiodothyronine; D008713:Methimazole; D011441:Propylthiouracil; D013954:Thyroglobulin; D011239:Prednisolone; D013974:Thyroxine